TT Capital Partners

Dawn Owens and Tom Tiller Jr. lead the firm as CEO and managing partner, respectively. Ryan Engle and Casey Carlgren serve as partners and hold voting seats on the investment committee. All four principals held senior roles at UnitedHealth Group or Optum prior to founding TT Capital in 2011.

TT Capital concentrates on two verticals within healthcare: healthcare IT, particularly software businesses that manage provider networks and claims analytics, and healthcare services, including alternate-site care delivery and pharmacy-benefit management. The firm typically avoids biotech, diagnostics, and device plays that fall outside its operator expertise.

TT Capital is a direct private equity investor. It structures both majority buyouts and minority growth-equity deals in lower-middle-market healthcare companies. The firm does not publicly market a fund-of-funds product or secondary vehicle.

Sourcing leverages the founding partners' operator network inside the managed-care ecosystem — former UnitedHealth Group and Optum division presidents, regional plan leaders, and provider-group executives. This network surfaces founder-owned companies where the owner is wrestling with a reimbursement or regulatory shift that the TT Capital team has already navigated inside a large payer organization.

The firm has historically syndicated with other sector-focused funds when a deal exceeds its equity-target range, but co-investment rights with limited partners are not publicly disclosed. TT Capital has also held board seats alongside growth-stage healthcare funds on select portfolio companies, per public record.